M1FG
DCPH

Mach-1 Financial Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Mach-1 Financial Group’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed – – 218
2021
Q1 		$0 Buy
+1
New +$47 ﹤0.01% 239

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Mach-1 Financial Group's DCPH Position: Q2 2021 in Review

Mach-1 Financial Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2021, closing a stake of 1 share.

Mach-1 Financial Group first reported a position in DCPH in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

  • Mach-1 Financial Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Mach-1 Financial Group sold 1 Deciphera Pharmaceuticals, Inc. Common Stock share in Q2 2021.
  • Mach-1 Financial Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Mach-1 Financial Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $0 in Q1 2021.
  • 147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Mach-1 Financial Group's 13F filing for Q2 2021, filed 4 Aug 2021.